KEVIN L SNYDER

Allopathic & Osteopathic Physicians|Internal Medicine BEL AIR, MD NPI 1174583959

General Payments — all program years on this page

$4,701.79

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 243
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $872.22 across 43 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $872.2243

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $670.9235
2019 $645.6134
2020 $270.3016
2021 $382.5530
2022 $795.1639
2023 $1,065.0346
2024 $872.2243

Records — PY2024 (43)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096914136 Novo Nordisk Inc $15.82 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096973252 Novo Nordisk Inc $19.06 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097117437 Novo Nordisk Inc $25.38 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097337774 Novo Nordisk Inc $13.24 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104373103 AstraZeneca Pharmaceuticals LP $17.32 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104679113 AstraZeneca Pharmaceuticals LP $24.13 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105597437 AstraZeneca Pharmaceuticals LP $100.01 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105626549 AstraZeneca Pharmaceuticals LP $17.20 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105642340 AstraZeneca Pharmaceuticals LP $18.80 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130882 ABBVIE INC. $13.08 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130884 ABBVIE INC. $30.23 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130886 ABBVIE INC. $3.59 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130888 ABBVIE INC. $24.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130890 ABBVIE INC. $4.66 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130892 ABBVIE INC. $26.45 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130894 ABBVIE INC. $9.12 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130896 ABBVIE INC. $32.93 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130898 ABBVIE INC. $2.49 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130900 ABBVIE INC. $31.50 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130902 ABBVIE INC. $3.36 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130904 ABBVIE INC. $4.62 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130906 ABBVIE INC. $26.00 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106130908 ABBVIE INC. $20.23 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111712339 Amgen Inc. $20.59 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111712341 Amgen Inc. $22.09 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115806437 GlaxoSmithKline, LLC. $19.96 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116104843 GlaxoSmithKline, LLC. $26.01 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116393914 GlaxoSmithKline, LLC. $21.94 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117902778 Boehringer Ingelheim Pharmaceuticals, Inc. $15.87 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132102825 PFIZER INC. $14.19 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135104481 Lilly USA, LLC $22.42 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135104483 Lilly USA, LLC $17.21 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135111592 Lilly USA, LLC $18.80 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135134064 Lilly USA, LLC $17.04 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136176101 Orexo US, Inc. $17.74 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136176103 Orexo US, Inc. $17.32 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136177112 Orexo US, Inc. $16.09 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136178132 Orexo US, Inc. $14.94 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136178134 Orexo US, Inc. $16.25 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144538626 Indivior Inc. $20.01 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144538628 Indivior Inc. $27.96 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144538630 Indivior Inc. $27.99 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151127932 Phathom Pharmaceuticals, Inc. $14.58 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.